Cargando…
Optimization of Long-Acting Bronchodilator Dose Ratios Using Isolated Guinea Pig Tracheal Rings for Synergistic Combination Therapy in Asthma and COPD
The co-administration of a long-acting β2-agonist (LABA), and a long-acting muscarinic antagonist (LAMA), has been shown to be beneficial in the management of non-communicable chronic respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD). The resulting relaxation of t...
Autores principales: | Menchi, Elena, El Khattabi, Charaf, Pochet, Stéphanie, Denis, Olivier, Amighi, Karim, Wauthoz, Nathalie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9416144/ https://www.ncbi.nlm.nih.gov/pubmed/36015111 http://dx.doi.org/10.3390/ph15080963 |
Ejemplares similares
-
Bronchodilator responsiveness or reversibility in asthma and COPD – a need for clarity
por: Barjaktarevic, Igor, et al.
Publicado: (2018) -
Which bronchodilator in COPD?
por: Russell, Richard, et al.
Publicado: (2007) -
COPD: maximization of bronchodilation
por: Nardini, Stefano, et al.
Publicado: (2014) -
Predicting treatable traits for long-acting bronchodilators in patients with stable COPD
por: Kang, Jieun, et al.
Publicado: (2017) -
Is there a rationale and role for long-acting anticholinergic bronchodilators in asthma?
por: Price, David, et al.
Publicado: (2014)